$ENDP News

Last published 3y ago

3y agoENDPC3i partners with Paladin Labs Inc. to offer Canadian clinicians a complimentary testing service to detect T315I mutationPR NewswireMONTREAL, June 12, 2023 /PRNewswire/ - C3i Center Inc and Paladin Labs Inc., a subsidiary of Endo International plc (NASDAQ:ENDP), have partnered to launch a complimentary clinical testing program for the diagnosis of
4y agoLMT ENDP NOCContracts for Sept. 1, 2022U.S. Department of WarNAVY Sikorsky Aircraft Corp., a Lockheed Martin Co., Stratford, Connecticut, is awarded a $39,920,367 firm-fixed-price modification (P00001) to an order (N0001922F2491) against a previously issued basic ordering agreement (N0001919G0029). This modification adds scope to provide production and installation of a VH-92A Flight Training Device (FTD) and updates to a previously delivered VH-92A FTD for ...
4y agoENDPEndo Enters Into Restructuring Support Agreement with Senior Secured Debtholders to Strengthen Financial Position and Advance Ongoing Business TransformationPR NewswireSale Transaction Would Result in a Substantial Reduction of Debt and Contemplates Purchaser-Established Voluntary Trusts Funded with $550 Million to Benefit Opioid Claimants Patients and Customers Will Continue to Receive Highest Quality Products and E
4y agoENDPNew Drug Filing for Cenobamate Accepted for Review in Canada and IsraelPR NewswireSK Biopharmaceuticals is eligible to receive milestones for future approval and commercialization in Canada and Israel PANGYO, South Korea, Aug. 9, 2022 /PRNewswire/ -- SK Biopharmaceuticals, Co., Ltd. announced that Health Canada has accepted Paladin
4y agoENDPENDO REPORTS SECOND-QUARTER 2022 FINANCIAL RESULTSPR NewswireDUBLIN, Aug. 9, 2022 /PRNewswire/ -- Endo International plc (NASDAQ:ENDP) today reported financial results for the second-quarter ended June 30, 2022.
4y agoENDPBuxton Helmsley Issues Letter to Endo International Plc. Directors, Relating to Financial DisclosuresBusiness WireThe Buxton Helmsley Group, Inc. (together with certain of its affiliates and clients, "BHG" or "we"), the New York City-based investment advisor to clients with financial interests in Endo International Plc. ("Endo" or the "Company") (NASDAQ:ENDP),today
4y agoENDP QNRXQuoin Pharmaceuticals and Endo Ventures Limited Enter Into Exclusive Distribution and Supply AgreementsGlobeNewswireASHBURN, Va., July 15, 2022 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Inc. (NASDAQ:QNRX) (the "Company" or "Quoin"), a specialty pharmaceutical company focused on rare and orphan diseases, has entered into the License and Distribution Agreement and the
4y agoENDP QNRXEndo Announces Agreement for Paladin Labs to Develop, Commercialize and Supply Quoin Pharmaceuticals' QRX003 in CanadaPR NewswireThe product is under investigation for the treatment of Netherton syndrome, a rare disease DUBLIN, July 15, 2022 /PRNewswire/ -- Endo International plc (NASDAQ:ENDP) announced today that its subsidiary Endo Ventures Limited has entered into agreements
4y agoENDPOpana® ER Antitrust Trial Concludes With Jury Verdict in Endo's FavorPR NewswireDUBLIN, July 1, 2022 /PRNewswire/ -- Endo International plc (NASDAQ:ENDP) announced today that a federal jury in Chicago, Illinois, has returned a verdict in favor of the Company's subsidiaries Endo Pharmaceuticals Inc. and Endo Health Solutions Inc. (co
4y agoENDPEndo Provides Top-Line Results from Phase 2 Study of Collagenase Clostridium Histolyticum (CCH) in Participants with Adhesive Capsulitis of the ShoulderPR NewswireDUBLIN, July 1, 2022 /PRNewswire/ -- Endo International plc (NASDAQ:ENDP) today announced top-line results from its Phase 2 study of Collagenase Clostridium Histolyticum (or "CCH") in participants with adhesive capsulitis (AC) of the shoulder, commonly k
4y agoENDP TLCTLC Announces TLC599 Agreement with EndoGlobeNewswireSOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, June 13, 2022 (GLOBE NEWSWIRE) -- TLC BioSciences (TLC), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical need, today announced that it has
4y agoENDPEndo Executes Agreement With TLC to Commercialize Phase 3 Orthopedic Product for the Treatment of Osteoarthritis Knee PainPR NewswireDUBLIN, June 13, 2022 /PRNewswire/ -- Endo International plc (NASDAQ:ENDP) announced today that its subsidiary Endo Ventures Limited (EVL) has executed an agreement with Taiwan Liposome Company, Ltd. (TLC), a clinical-stage specialty pharmaceutical compa
4y agoENDPNational Survey of Over 1,500 Men Shows More Than Half Were Unsure of How to Improve Their Mental and Sexual Health; New Partnership Aims to Change That Through Education and Free Virtual ConsultationsPR NewswireEndo, Vault Health, the Sexual Medicine Society of North America (SMSNA) and Men's Health Network (MHN) join forces to launch Healthy Now: A Men's Health Coalition™ to encourage men to make all aspects of their health—physical, mental and sexual—a
4y agoCERN ENDP GHL IPGP+17Keurig Dr Pepper, VICI Properties and ON Semiconductor Set to Join S&P 500; Others to Join S&P MidCap 400, and S&P SmallCap 600PR NewswireNEW YORK, June 3, 2022 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400 and S&P SmallCap 600 indices: VICI Properties Inc. (NYSE:VICI) will replace Cerner Corp. (NASD: CERN) in the S&P 50
4y agoENDPBuxton Helmsley Issues Letter to Endo International Plc. Shareholders and Creditors, Relating to Corporate Malfeasance and False Statements of FinancialsBusiness WireThe Buxton Helmsley Group, Inc. (together with certain of its affiliates and clients, "BHG" or "we"), the New York City-based investment advisor to clients with financial interests in Endo International Plc. ("Endo" or the "Company") (NASDAQ:ENDP), toda
4y agoBBIG CLVS DBGI ENDP+1Thinking about buying stock in Vinco Ventures, Digital Brands, Endo, Clovis Oncology, or Under Armour?PR NewswireNEW YORK, May 6, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BBIG, DBGI, ENDP, CLVS, and UAA. To
4y agoENDPENDO REPORTS FIRST-QUARTER 2022 FINANCIAL RESULTSPR NewswireDUBLIN, May 5, 2022 /PRNewswire/ -- Endo International plc (NASDAQ:ENDP) today reported financial results for the first-quarter ended March 31, 2022 and provided second-quarter 2022 financial guidance.
4y agoENDPEndo Aesthetics to Introduce New Clinical Study of Qwo® (collagenase clostridium histolyticum-aaes) at the Annual SCALE MeetingPR NewswireDUBLIN, May 5, 2022 /PRNewswire/ -- Endo International plc (NASDAQ:ENDP) today announced the upcoming launch of a new clinical study relevant to the use of Qwo® (collagenase clostridium histolyticum-aaes) for the treatment of moderate to severe cellulit
4y agoBLTE CLVS ENDP ONCY+1HER2-Targeted Therapies Introduced Early in Breast Cancer Treatment Offering Hope for PatientsPR NewswirePALM BEACH, Fla. , May 4, 2022 /PRNewswire/ -- FinancialNewsMedia.com News Commentary - Globally, the R&D on breast cancer in all its forms has been steadily growing at a significant pace over the last several years and will continue in the years to com
4y agoBRQS ENDP LCID SESN+1Thinking about buying stock in Lucid Group, Sesen Bio, Borqs Technologies, Endo International, or Spero Therapeutics?PR NewswireNEW YORK, May 3, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for LCID, SESN, BRQS, ENDP, and SPRO. T
4y agoENDPEndo Acquires Six Development-Stage, Ready-to-Use Injectable Product Candidates From NevakarPR NewswireDUBLIN, May 2, 2022 /PRNewswire/ -- Endo International plc (NASDAQ:ENDP) announced today that its subsidiary Endo Ventures Limited (EVL) acquired six development-stage, ready-to-use injectable product candidates from Nevakar Injectables Inc., a subsidiar
4y agoENDPNevakar Injectables Sells Six Development-Stage, Ready-to-Use Injectable Product Candidates to Endo Ventures LimitedGlobeNewswireBRIDGEWATER, N.J., May 02, 2022 (GLOBE NEWSWIRE) -- Nevakar Injectables Inc. ("Nevakar"), a wholly owned subsidiary of Nevakar, Inc., is a biopharmaceutical company developing multiple sterile injectable products for use in the critical and ambulatory
4y agoENDPNevakar Injectables Receives U.S. FDA Approval of Ready-to-Use Ephedrine Injection in a Prefilled SyringeGlobeNewswireBRIDGEWATER, N.J., April 28, 2022 (GLOBE NEWSWIRE) -- Nevakar Injectables Inc. ("Nevakar"), a wholly owned subsidiary of Nevakar, Inc., is a biopharmaceutical company developing multiple sterile injectable products for use in the critical and ambulator
4y agoENDPTennessee Court of Appeals Orders Recusal of Trial Court Judge and Vacates Default Judgment on Liability Against EndoPR NewswireDUBLIN, April 20, 2022 /PRNewswire/ -- Endo International plc (NASDAQ:ENDP) today announced that the Tennessee Court of Appeals has reversed a trial court judge's order denying a motion for recusal by Endo's wholly-owned subsidiaries Endo Health Solutio
4y agoENDPMedical spas are seeing a boost in beauty procedures as people emerge from two pandemic years at homeCNBCSpecializing in aesthetic services, medspas across the country have been seeing a rise in robust treatment plans for both face and body in the past year.
4y agoENDPEndo to Announce First-Quarter 2022 Financial ResultsPR NewswireDUBLIN, April 12, 2022 /PRNewswire/ -- Endo International plc (NASDAQ:ENDP) will announce its first–quarter 2022 financial results on May 5, 2022 and members of its senior management team will host a conference call and webcast on May 6, 2022 at 7:30am
4y agoENDPNevakar Injectables Announces the Launch of Ready-to-Use Ephedrine Injection VialsGlobeNewswireBRIDGEWATER, N.J., March 28, 2022 (GLOBE NEWSWIRE) -- Nevakar Injectables Inc., a biopharmaceutical company developing multiple sterile injectable products for use in the critical and ambulatory care settings, announced today the launch of its ready-to
4y agoENDPEndo Begins Shipment of Premixed Ephedrine Sulfate Injection in Ready-to-Use VialsPR NewswireDUBLIN, March 28, 2022 /PRNewswire/ -- Endo International plc (NASDAQ:ENDP) announced today that its Par Sterile Products business has begun shipping premixed Ephedrine Sulfate Injection in a ready-to-use 50 mg/10 ml single-use vial.
4y agoENDPEndo Launches New Living Our Values Program to Recognize Outstanding Team MembersPR NewswireDUBLIN, March 3, 2022 /PRNewswire/ -- Endo International plc (NASDAQ:ENDP) today honored select team members from across the world who exemplify Endo's Values as part of its inaugural Living Our Values Award program.
4y agoENDPButt First: Endo Launches First Direct-to-Consumer Campaign for Qwo® (collagenase clostridium histolyticum-aaes) With 200+ Patient EventsPR NewswireDUBLIN, March 2, 2022 /PRNewswire/ -- Endo International plc (NASDAQ:ENDP) has kicked off a series of more than 200 patient events that will be held across the United States as part of Butt First, a new direct-to-consumer awareness campaign designed to
4y agoENDPENDO REPORTS FOURTH-QUARTER AND FULL-YEAR 2021 FINANCIAL RESULTSPR NewswireDUBLIN, Feb. 28, 2022 /PRNewswire/ -- Endo International plc (NASDAQ:ENDP) today reported financial results for the fourth-quarter and full-year ended December 31, 2021 and introduced first-quarter 2022 financial guidance.
4y agoENDPEndo Comments on Default Judgment on Liability in Tennessee State CourtPR NewswireDUBLIN,, Feb. 11, 2022 /PRNewswire/ -- Endo International plc (NASDAQ:ENDP) today announced that it expects a Tennessee state court to issue an order granting plaintiffs' request for a default judgment on liability against Endo's wholly-owned
4y agoENDPEndo Announces Launch of Ready-to-Use VASOSTRICT® (vasopressin injection, USP) in Pre-Mix BottlesPR NewswireDUBLIN, Feb. 7, 2022 /PRNewswire/ -- First and only manufacturer-prepared, FDA approved vasopressin in a premixed ready-to-use (R
4y agoENDPEndo to Announce Fourth Quarter and Full-Year 2021 Financial ResultsPR NewswireDUBLIN, Jan. 25, 2022 /PRNewswire/ -- Endo International plc (NASDAQ:ENDP) will announce its fourth–quarter and full-year 2021 financial results on February 28, 2022 and members of its senior management team will host a conference call and webcast on
4y agoENDPEndo Reaches Agreement Intended to Settle Florida Governmental Opioid Cases and ClaimsPR NewswireDUBLIN, Jan. 18, 2022 /PRNewswire/ -- Endo International plc (NASDAQ:ENDP) ("Endo") today announced that it and its wholly-owned subsidiaries Endo Pharmaceuticals Inc. and Endo Health Solutions Inc. have entered into a statewide settlement agreement int
4y agoENDPEndo Announces Publication of New AVEED® (testosterone undecanoate) Data in Peer-Reviewed Journal of Clinical Pharmacology; Data Evaluates Dosing Flexibility in Men With HypogonadismPR NewswireDUBLIN, Jan. 13, 2022 /PRNewswire/ -- Pharmacokinetic simulation modeling study predicted more frequent administration with shorte
4y agoENDPEndo Appoints Dr. James P. Tursi as Executive Vice President, Global Research & DevelopmentPR NewswireDUBLIN, Jan. 11, 2022 /PRNewswire/ -- Endo International plc (NASDAQ:ENDP) today announced the appointment of Dr. James P. Tursi as Executive Vice President, Global Research & Development effective January 18, 2022. He will join the Company's Senior Ex
4y agoENDPEndo Launches New Dupuytren's Contracture Campaign Featuring Real Patients: Watching Education UnfoldPR NewswireDUBLIN, Jan. 10, 2022 /PRNewswire/ -- The campaign features real Dupuytren's contracture (DC) patients and aims to address patient
4y agoENDPEndo Launches First Generic Version of CUVPOSA® (glycopyrrolate) Oral SolutionPR NewswireDUBLIN, Jan. 4, 2022 /PRNewswire/ -- Endo International plc (NASDAQ:ENDP) announced today that one of its operating companies, Par Pharmaceutical, Inc. (Par), has begun shipping the first generic version of Merz's CUVPOSA® (glycopyrrolate) 1 mg/5 mL ora
4y agoENDPEndo to Participate at J.P. Morgan 40th Annual Healthcare ConferencePR NewswireDUBLIN, Jan. 4, 2022 /PRNewswire/ -- Endo International plc (NASDAQ:ENDP) announced today that members of management will present at the J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022 at 8:15 a.m. EST. A live webcast and audio archive
4y agoENDPEndo Reaches Agreement Intended to Settle Texas Governmental Opioid Cases and ClaimsPR NewswireDUBLIN, Dec. 23, 2021 /PRNewswire/ -- Endo International plc (NASDAQ:ENDP) ("Endo") today announced that it and its wholly-owned subsidiaries Endo Pharmaceuticals Inc., Endo Health Solutions Inc., Par Pharmaceutical, Inc., and Par Pharmaceutical Companie
4y agoENDPEndo Announces Agreement for Paladin Labs to Commercialize SK Biopharmaceuticals' XCOPRI® (Cenobamate) in CanadaPR NewswireDUBLIN, Dec. 23, 2021 /PRNewswire/ -- Endo International plc (NASDAQ:ENDP) announced today that its subsidiary Endo Ventures Limited has entered into definitive agreements with SK Biopharmaceuticals for the development, registration, supply, commerciali
4y agoENDPEndo Announces Favorable Final Ruling in California State Court Opioid TrialPR NewswireDUBLIN, Dec. 15, 2021 /PRNewswire/ -- Endo International plc (NASDAQ:ENDP) ("Endo") today announced that one of the first public nuisance cases filed against manufacturers of prescription opioid medications has ended with a California trial court issui
4y agoENDPEndo's Qwo® (collagenase clostridium histolyticum-aaes) Data Presented at the American Society for Dermatologic Surgery's Annual MeetingPR NewswireDUBLIN, Nov. 22, 2021 /PRNewswire/ -- Endo International plc (NASDAQ:ENDP) announced today that data from clinical and non-clinical studies of Endo Aesthetics' Qwo® (collagenase clostridium histolyticum-aaes), which received FDA approval in July 2020 fo
4y agoENDPEndo Begins Shipment of Generic MIACALCIN® (calcitonin salmon) InjectionPR NewswireDUBLIN, Nov. 18, 2021 /PRNewswire/ -- Endo International plc (NASDAQ:ENDP) announced today that its Par Sterile Products business has begun shipping calcitonin salmon injection, USP, multi-dose vials (2 mL) following final approval from the U.S. Food an
4y agoENDPEndo Announces Fill-Finish Manufacturing Agreement with U.S. Government to Support Production of Critical MedicinesPR NewswireAgreement to fund expansion of Rochester, MI facility to support fill-finish manufacturing of both mRNA and adenovirus vaccines DUBLIN, Nov. 17, 2021 /PRNewswire/ -- Endo International plc (NASDAQ:ENDP) (Endo) today announced that its subsidiary,
5y agoENDPEndo Announces Agreement with Premier to Supply VASOSTRICT® (vasopressin injection, USP) Vials, Essential for COVID-19 CarePR NewswireDUBLIN, Nov. 8, 2021 /PRNewswire/ -- Endo International plc (NASDAQ:ENDP) today announced that its Par Sterile Products business will supply VASOSTRICT®, vasopressin injection, USP, vial presentations to healthcare providers through Premier's Premier P
5y agoARDX ENDP GOOS NKLA+1Thinking about buying stock in Ardelyx, Endo International, Phunware, Canada Goose Holdings, or Nikola Corp?PR NewswireNEW YORK, Nov. 5, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ARDX, ENDP, PHUN, GOOS, and NKLA. T
5y agoENDPEndo International Plc (ENDP) Q3 2021 Earnings Call TranscriptEarnings Call TranscriptsENDP earnings call for the period ending September 30, 2021.
5y agoENDPEndo Reports Third-Quarter 2021 Financial Results And Raises 2021 Financial GuidancePR NewswireDUBLIN, Nov. 4, 2021 /PRNewswire/ -- Endo International plc (NASDAQ:ENDP) today reported financial results for the third-quarter ended September 30, 2021.